Sciatica is driven by inflammation at the nerve root as much as by compression. Here is how MSC-derived exosomes are thought to act, and an honest read of the 2026 human evidence.
CATEGORY ARCHIVE
Patient Education
Patient guides: what to expect, costs, recovery, FAQs, and treatment comparisons.
Regenerative Medicine in Salt Lake City: Exosome Therapy, Stem Cells & Peptide Treatments
Exosome therapy, stem cells, PRP and peptides in Salt Lake City. Real costs, what the evidence shows, FDA status, and how to vet a Wasatch Front clinic.
Exosome Storage and Handling: What the Cold Chain Does to Product Quality
What 50 pooled studies say about exosome storage and handling: minus 80 storage, freeze-thaw damage, formulation, and the questions to ask a supplier.
Exosome Dosing: What 66 Clinical Trials Say About Getting the Number Right
A review of 66 registered MSC-derived extracellular vesicle trials finds that route of delivery, not volume, sets the effective dose, and that only six trials reported enough detail to analyse dose at all.
Exosome Therapy vs. Hyaluronic Acid Injections for Knee Osteoarthritis
One option has decades of human trials and guideline bodies recommending against routine use. The other has promising biology and almost no controlled human data. Here is how to weigh exosome therapy against hyaluronic acid injections for knee osteoarthritis.
Regenerative Medicine in New Orleans: Exosome Therapy, Stem Cells & Peptide Treatments
Exosome therapy, stem cells, PRP and peptides in New Orleans. Real costs, what the evidence shows, FDA status, and how to vet a clinic.
Exosome Therapy for Achilles Tendinopathy: What the Evidence Actually Shows
Exosome therapy for Achilles tendinopathy is heavily marketed and thinly evidenced. Here is what the biology suggests, what the published research has and has not established, and how to evaluate the option.
Exosome Therapy for Autoimmune Disease: What the 2026 Evidence Shows
A March 2026 review in Clinical Rheumatology examined exosomes as immunotherapy for autoimmune rheumatic disease. Here is what the evidence supports, where it stops, and why no exosome product is FDA approved.
Exosome Certificate of Analysis: The Four Numbers a 2026 Review Says Must Be On It
A 2026 Advanced Science review argues the exosome field must become a quantitative measurement science. Here are the four attributes it says every batch should document.
Exosome Therapy for Tennis Elbow: What the 2026 Evidence Actually Shows
Exosome therapy for tennis elbow explained: why lateral epicondylitis is degeneration not inflammation, what the cortisone and PRP data show, and where MSC-derived exosomes actually stand in 2026.
Regenerative Medicine in Louisville: Exosome Therapy, Stem Cells & Peptide Treatments
A patient guide to exosome therapy, stem cell therapy, PRP and peptide treatments in Louisville, KY, including realistic costs, evidence, and how to vet providers.
How Many Exosome Treatments Do You Need? A 2026 Guide to Course Length
How many exosome treatments do you need? See the course lengths clinics use for joints, IV, skin and hair, and what the 2026 evidence actually supports.
Exosome Therapy for Plantar Fasciitis: A 2026 Guide to Regenerative Heel Pain Treatment
Exosome therapy for plantar fasciitis is one of the newest questions patients bring to regenerative medicine clinics,...
Regenerative Medicine in Oklahoma City: Exosome Therapy, Stem Cells & Peptide Treatments
Oklahoma City has quietly become one of the most interesting places in the Southern Plains to seek regenerative...
Who Is a Candidate for Exosome Therapy? A 2026 Guide to Suitability and Safety
Wondering if you are a candidate for exosome therapy? Learn who benefits most, the key contraindications, and how responsible providers screen patients in 2026.
Peptide Therapy vs Conventional Treatment: A 2026 Patient Guide
Comparing peptide therapy vs conventional treatment is not a contest between old medicine and new medicine. It is a...
Regenerative Medicine in St. Louis: Exosome Therapy, Stem Cells & Peptide Treatments
St. Louis is one of the few American cities where you can drive twenty minutes from a laboratory doing federally...
Exosome Therapy Cost in 2026: What You Are Actually Paying For
Exosome therapy cost is one of the most searched questions in regenerative medicine, and it is also one of the hardest...
What the Latest Research Says About MSC-Derived Exosomes (And What the FDA Says)
A 2025 review of 66 MSC-derived exosome clinical trials shows real progress, but there are still no FDA-approved exosome products. Here is what the research shows, what it does not, and how to read exosome claims as an informed consumer.
The Lancet Publishes Phase 3 HOPE-3 Data: What Peer Review Changes for Exosome Science
The Lancet has published the full Phase 3 HOPE-3 results for deramiocel, an investigational cell therapy whose effect is attributed to secreted exosomes. What independent peer review does and does not establish.